New Delhi, Oct. 23 -- SRF Ltd's September quarter (Q2FY27) results reveal that pain for the specialty chemicals business has persisted. Although the management is rooting for a better H2, the Street is not fully convinced.

While the SRF stock recovered on Friday after hitting a new 52-week low of Rs.2,178.30 on the National Stock Exchange on Thursday, it has declined 23% so far in CY26. In Q2, revenue rose 35% year-on-year to Rs.4,904 crore, falling 3% sequentially.

Revenue in the chemicals business grew 25%, driven by a robust performance in fluorochemicals, which was backed by higher volumes and improved realizations. However, specialty chemicals remained subdued. The films & foil and technical textiles businesses fared relatively bet...